Free Trial

Repare Therapeutics (RPTX) SEC Filings & 10K Form

Repare Therapeutics logo
$1.29 -0.03 (-2.27%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.26 -0.03 (-1.94%)
As of 02/21/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Repare Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2025
10:23 AM
ARK Investment Management LLC (Filed by)
Repare Therapeutics (Subject)
Form SCHEDULE 13G/A
01/31/2025
3:15 PM
MPM BioVentures 2014, L.P. (Filed by)
Repare Therapeutics (Subject)
Form SCHEDULE 13D/A
01/15/2025
5:43 PM
MPM BioVentures 2014, L.P. (Filed by)
Repare Therapeutics (Subject)
Form SCHEDULE 13D/A
01/10/2025
6:01 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:49 PM
MPM BioVentures 2014, L.P. (Filed by)
Repare Therapeutics (Subject)
Form SCHEDULE 13D/A
12/26/2024
3:34 PM
MPM BioVentures 2014, L.P. (Filed by)
Repare Therapeutics (Subject)
Form SCHEDULE 13D/A
12/12/2024
3:28 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:00 PM
Redmile Group, LLC (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:42 AM
Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
11/07/2024
7:33 AM
Repare Therapeutics (Filer)
Form 424B5
11/07/2024
6:10 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:15 AM
Repare Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
11:15 PM
Repare Therapeutics (Filer)
Form EFFECT
08/07/2024
8:06 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:41 PM
Repare Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2024
3:20 PM
Repare Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2024
3:27 PM
Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
3:36 PM
Repare Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Civik Thomas (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Bonita David P (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Kulkarni Samarth (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Molineaux Susan (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Morrison Briggs (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Repare Therapeutics (Issuer)
RHOADS ANN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:06 PM
Repare Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/26/2024
3:14 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:27 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:28 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:30 PM
Forte Steve (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:31 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:54 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:56 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:57 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:59 PM
Forte Steve (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
11:37 AM
Forte Steve (Reporting)
Repare Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
1:50 PM
Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
6:25 PM
Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:23 PM
Koehler Maria (Reporting)
Repare Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:23 PM
Repare Therapeutics (Subject)
Zinda Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
8:02 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.
03/04/2024
8:04 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:06 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:10 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:15 AM
Repare Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RPTX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners